Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-08-28
1989-04-25
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514210, 514219, 514248, 514250, 514257, 514278, 5142288, 5142308, 540203, 540353, 540492, 540493, 544 71, 544231, 546 18, A61K 31415, A61K 31305, C07D45500, C07D47120
Patent
active
048248495
ABSTRACT:
Substituted hexahydro arylquinolizines and pharmaceutically acceptable salts thereof are selective .alpha..sub.2 -adrenergic receptor antagonists and thereby useful as antidepressants, antihypertensives, ocular antihypertensives, antidiabetics, platelet aggregation inhibitors, antiobesity agents, and modifiers of gastrointestinal motility.
REFERENCES:
patent: 4710504 (1987-12-01), Baldwin et al.
Baldwin John J.
deSolms Jane
Guare, Jr. James P.
Huff Joel R.
Vacca Joseph P.
Lee Mary C.
Merck & Co. , Inc.
Nicholson William H.
Northington Zinna
Sudol, Jr. Michael C.
LandOfFree
.alpha..sub.2 -adrenoceptor antagonistic arylquinolizines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .alpha..sub.2 -adrenoceptor antagonistic arylquinolizines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha..sub.2 -adrenoceptor antagonistic arylquinolizines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1196020